SPRO
Spero Therapeutics·NASDAQ
--
--(--)
--
--(--)
SPRO fundamentals
Spero Therapeutics (SPRO) released its earnings on Mar 26, 2026: revenue was 41.30M (YoY +174.51%), beat estimates; EPS was 0.53 (YoY +239.47%), beat estimates.
Revenue / YoY
41.30M
+174.51%
EPS / YoY
0.53
+239.47%
Report date
Mar 26, 2026
Earnings
EPS
Revenue
Revenue & Expenses
SPRO has released its 2025 Q4 earnings report, with revenue of 41.30M, reflecting a YoY change of 174.51%, and net profit of 31.52M, showing a YoY change of 250.90%. The Sankey diagram below clearly presents SPRO's revenue sources and cost distribution.
Key Indicators
Spero Therapeutics (SPRO) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Spero Therapeutics (SPRO)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Spero Therapeutics (SPRO)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Spero Therapeutics (SPRO)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Spero Therapeutics (SPRO) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Spero Therapeutics (SPRO) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Spero Therapeutics year over year?Did Spero Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Spero Therapeutics's revenue and profit?What were the key takeaways from Spero Therapeutics's earnings call?What is Spero Therapeutics's latest dividend and current dividend yield?What does Spero Therapeutics do and what are its main business segments?What is the market's earnings forecast for Spero Therapeutics next quarter?What guidance did Spero Therapeutics's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
